Market to stay muted; RBL bank, Suven Life sciences in focus
In this episode, find out why the central government has placed an order for 16 cr doses of Covid vaccine, why reliance Industries has set its eye on the pharma sector.
Available Episodes Newest First Oldest First EPISODE 550 30 Apr 2024 Why investors don't want unicorns; behind Udaan’s pivot Read more
Why investors don't want unicorns; behind Udaan’s pivot Read more
EPISODE 549 29 Apr 2024 A profile of Abhinav Bindra in 2024, the state of Indian IT stocks Read more
A profile of Abhinav Bindra in 2024, the state of Indian IT stocks Read more
EPISODE 548 26 Apr 2024 Understanding packaged food risks; Why are global media companies exiting India? Read more
Understanding packaged food risks; Why are global media companies exiting India? Read more
EPISODE 547 25 Apr 2024 Tata Sons' board revamp, illegal betting apps Read more
Tata Sons' board revamp, illegal betting apps Read more
EPISODE 546 24 Apr 2024 Mercury to remain on the rise; The journey of Adani’s real estate ventures Read more
Mercury to remain on the rise; The journey of Adani’s real estate ventures Read more
EPISODE 545 23 Apr 2024 An independent candidate out of Barmer, tier-2 India's e-commerce boom Read more
An independent candidate out of Barmer, tier-2 India's e-commerce boom Read more
EPISODE 544 22 Apr 2024 Bengaluru water crisis: How corporate fares; How Taylor Swift helped promote 5G Read more
Bengaluru water crisis: How corporate fares; How Taylor Swift helped promote 5G Read more
EPISODE 543 19 Apr 2024 Infosys’ poor results provide little hope, understanding monsoon predictions Read more
Infosys’ poor results provide little hope, understanding monsoon predictions Read more
EPISODE 542 18 Apr 2024 Indian aerospace startups to meet Musk, the people still bullish on crypto Read more
Indian aerospace startups to meet Musk, the people still bullish on crypto Read more
EPISODE 541 17 Apr 2024 Smartphone sales see turnaround; Mid-budget Bollywood on a resurgence Read more
Smartphone sales see turnaround; Mid-budget Bollywood on a resurgence Read more
